Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Warren

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|April 13, 2001
The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cellsR A Izydore, Y Zhang, X Zhou, et al.
Archiv Der Pharmazie|May 31, 2001
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinedionesI H Hall, B J Barnes, E S Ward, et al.
Archiv Der Pharmazie|August 22, 2001
Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivativesI H Hall, B J Barnes, E S Ward, et al.
Archiv Der Pharmazie|January 9, 1999
Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cellsB S Burnham, J T Gupton, K Krumpe, et al.
Archiv Der Pharmazie|February 17, 2000
Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cellsJ T Gupton, B S Burham, K Krumpe, et al.
Die Pharmazie|October 16, 1999
The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt4 leukemia cellsJ T Gupton, B S Burham, B D Byrd, et al.
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|November 3, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent PsychiatryR Hamilton, C Gray, S A Bélanger, et al.
The Canadian Journal of Cardiology|November 10, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent PsychiatryA E Warren, R M Hamilton, S A Bélanger, et al.
Paediatrics & Child Health|November 2, 2010
Cardiac risk assessment before the use of stimulant medications in children and youthS A Bélanger, A E Warren, R M Hamilton, et al.
Clinical EEG and Neuroscience|December 26, 2013
Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013B J He, G Nolte, K Nagata, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|April 13, 2001
The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cellsR A Izydore, Y Zhang, X Zhou, et al.
Archiv Der Pharmazie|May 31, 2001
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinedionesI H Hall, B J Barnes, E S Ward, et al.
Archiv Der Pharmazie|August 22, 2001
Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivativesI H Hall, B J Barnes, E S Ward, et al.
Archiv Der Pharmazie|January 9, 1999
Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cellsB S Burnham, J T Gupton, K Krumpe, et al.
Archiv Der Pharmazie|February 17, 2000
Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cellsJ T Gupton, B S Burham, K Krumpe, et al.
Die Pharmazie|October 16, 1999
The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt4 leukemia cellsJ T Gupton, B S Burham, B D Byrd, et al.
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|November 3, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent PsychiatryR Hamilton, C Gray, S A Bélanger, et al.
The Canadian Journal of Cardiology|November 10, 2009
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent PsychiatryA E Warren, R M Hamilton, S A Bélanger, et al.
Paediatrics & Child Health|November 2, 2010
Cardiac risk assessment before the use of stimulant medications in children and youthS A Bélanger, A E Warren, R M Hamilton, et al.
Clinical EEG and Neuroscience|December 26, 2013
Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013B J He, G Nolte, K Nagata, et al.
Pageof 2